Study of the Cannabis Use of Minors Imprisoned in the PACA Region

September 4, 2018 updated by: Assistance Publique Hopitaux De Marseille

Study of the Cannabis Use of Minors Imprisoned in the PACA Region (France)

To date, there is little data on the consumption of young adults in detention.

The main objective of this project is to document the prevalence of problematic cannabis use before incarceration among juveniles detained in the various detention centers in the PACA

Secondary objectives are to document:

  • the prevalence of cannabis use over the course of life, last year and last month;
  • the prevalence of harm and risky behavior associated with the use of a psychoactive substance
  • associated addictions and first and foremost tobacco
  • the determinants (socio-demographic, socio-economic, environmental, etc.) of problem use and cannabis use.

This is a multicenter cross-sectional study aimed at establishing an exhaustive picture of the defined population region over a 12-month period.

The holder of the parental authority exercise and the individual agreeing to participate in the study must:

  • sign an informed consent a no objection card
  • complete a car book and hetero-questionnaires. The time of handover is evaluated at 30 minutes.

The CAST questionnaire will be used to answer the main purpose of the study and to identify consumers with problematic cannabis use.

CAST scores will be calculated. Abnormal CAST proportions will be presented along with their 95% confidence intervals. The links between the score and the various variables identified as determinants will be tested using uni and multivariate analyzes.

The assessment of the health status and needs of this extremely vulnerable population is a prerequisite for defining specific regional objectives and for establishing a coherent and coordinated effective health intervention within the community. prisoner in France.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

To date, there is little data on the consumption of young adults in detention when they are the first consumers in the general population in France and they represent a particularly vulnerable population within the prison population.

objectives The main objective of this project is to document the prevalence of problematic cannabis use before incarceration among juveniles detained in the various detention centers in the P.A.C.A.

Secondary objectives are to document:

  • the prevalence of cannabis use over the course of life, last year and last month;
  • the prevalence of harm and risky behavior associated with the use of a psychoactive substance
  • associated addictions and first and foremost tobacco
  • the determinants (socio-demographic, socio-economic, environmental, etc.) of problem use and cannabis use.

Method This is a multicenter cross-sectional study aimed at establishing an exhaustive picture of the defined population (juvenile detainees in the P.A.C.A.) region over a 12-month period.

The holder of the parental authority exercise and the individual agreeing to participate in the study must:

  • sign an informed consent a no objection card
  • complete a car book and hetero-questionnaires. The time of handover is evaluated at 30 minutes.

The CAST questionnaire will be used to answer the main purpose of the study and to identify consumers with problematic cannabis use.

CAST scores will be calculated. Abnormal CAST proportions will be presented along with their 95% confidence intervals. The links between the score and the various variables identified as determinants (socio-demographic, socio-economic, environmental, other addictions, etc.) will be tested using uni and multivariate analyzes.

Expected results The assessment of the health status and needs of this extremely vulnerable population is a prerequisite for defining specific regional objectives and for establishing a coherent and coordinated effective health intervention within the community. prisoner in France.

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Paca
      • Marseille, Paca, France, 13354
        • Assistance Publique des Hôpitaux de Marseille

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 14 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients new arriving in prison

Description

Inclusion Criteria:

  • Newcomer subject in detention,
  • Subject having been informed about the study and not expressing opposition to participating in the study.
  • Legal officer who was informed about the study and did not express any opposition to participate in the study.
  • Subject including French and able to fill self-questionnaires, and not presenting attacks of the severe cognitive functions

Exclusion Criteria:

Subject already incarcerated less than 6 months before its inclusion,

  • subject with severe hearing loss,
  • Subject not having agreed to participate in the study,
  • Holder of parental authority who has not given his consent,
  • Subject not including French.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental group
New child arriving in detention CAST questionnaire will be performed
the CAST questionnaire will be used to answer the main objective of the study and to identify consumers with problematic cannabis use. This is a validated self-questionnaire in France (Legleye et al., 2011), specific to the adolescent population, which is interpreted according to the score obtained (Bastiani et al., 2013, Legleye et al. 2007, Legleye et al., 2011). It includes 6 items with answer modes coded from 0 to 4. The total score obtained by summing these 6 items can therefore vary from 0 to 24. We define users without risk for a score of less than 3, users with low risk for a score greater than or equal to 3 and less than 7, and finally those with a risk of problematic use for a score greater than or equal to 7

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CAST questionnaire score
Time Frame: 30 minutes
the CAST questionnaire will be used to answer the main objective of the study and to identify consumers with problematic cannabis use. This is a validated self-questionnaire in France (Legleye et al., 2011), specific to the adolescent population, which is interpreted according to the score obtained. It includes 6 items with answer modes coded from 0 to 4. The total score obtained by summing these 6 items can therefore vary from 0 to 24. We define users without risk for a score of less than 3, users with low risk for a score greater than or equal to 3 and less than 7, and finally those with a risk of problematic use for a score greater than or equal to 7
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2019

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

June 1, 2020

Study Registration Dates

First Submitted

September 4, 2018

First Submitted That Met QC Criteria

September 4, 2018

First Posted (Actual)

September 6, 2018

Study Record Updates

Last Update Posted (Actual)

September 6, 2018

Last Update Submitted That Met QC Criteria

September 4, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2017-25

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe